Please assess the completion status of the following clinical trial:

Trial Title: Correlation Between Tissue and Plasmatic EGFR in CBNPC With EGFR Mutation or Predictive Factor of EGFR Mutation

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* At least 18 years~* Metastatic lung carcinoma~* With: - EGFR gene mutation~* Or at least 2 predictive factors of addictive mutation (Women, non smocking or cessation \> 3 years, Asiatic, lung adenocarcinoma)~* Eligible for 1st line treatment~* Performance status ≤ 3~* Available tumor sample or tumor reachable for biopsy~* With informed and signed consent~* Affiliation to the National Social Security System~Exclusion Criteria:~* Previous radiotherapy treatment in months preceding initials samples~* Pregnant or breastfeeding women~* Patient not able to give consent or unwilling to provide consent

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- study procedure (Type: EXPERIMENTAL): Clinical exam. Liquid biopsy. Diagnostic exam (biopsy and imagery). 1st line treatment. tumor evaluation. Biopsy

Based on this trial design, predict the completion outcome and termination type (if applicable).